Hematologic Diseases Clinical Trials

21 recruiting

Hematologic Diseases Trials at a Glance

22 actively recruiting trials for hematologic diseases are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Leuven, Palo Alto, and Haifa. Lead sponsors running hematologic diseases studies include Meyer Children's Hospital IRCCS, Bnai Zion Medical Center, and Universitaire Ziekenhuizen KU Leuven.

Browse hematologic diseases trials by phase

Treatments under study

About Hematologic Diseases Clinical Trials

Looking for clinical trials for Hematologic Diseases? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematologic Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematologic Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Not Applicable

Autologous Testicular Tissue Transplantation

CancerHematologic DiseasesSickle Cell Thalassemia
Universitair Ziekenhuis Brussel5 enrolled1 locationNCT05414045
Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting
Phase 1

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

Hematologic Diseases
Porteus, Matthew, MD22 enrolled1 locationNCT04640987
Recruiting
Phase 1

IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

NeoplasmsHematologic Diseases
Zhejiang University20 enrolled1 locationNCT07257640
Recruiting
Not Applicable

HEME Home Transfusion Program

LymphomaLeukemiaHematologic Malignancy+3 more
Dana-Farber Cancer Institute700 enrolled2 locationsNCT06487247
Recruiting
Phase 1Phase 2

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

NeoplasmsHematologic Diseases
Zhejiang University30 enrolled1 locationNCT05827835
Recruiting
Not Applicable

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Advanced Solid TumorsOncologyLymphoma+3 more
Azienda USL Reggio Emilia - IRCCS75 enrolled1 locationNCT06795815
Recruiting
Not Applicable

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

Hematologic Diseases
Alice Bertaina204 enrolled1 locationNCT04249830
Recruiting

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Hematologic Diseases
Invivoscribe, Inc.2,000 enrolled1 locationNCT06222164
Recruiting
Not Applicable

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

LeukemiaAcute Myeloid Leukemia in RemissionLymphoblastic Lymphoma+10 more
Medical College of Wisconsin40 enrolled1 locationNCT05794880
Recruiting

Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

OncologySurgical ComplicationPulmonary Disease+3 more
University Hospital Bispebjerg and Frederiksberg3,095 enrolled1 locationNCT05378139
Recruiting

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

ThrombocytopeniaHematologic DiseasesBleeding+1 more
Thomas Kander500 enrolled1 locationNCT06187831
Recruiting

Study on the Clinical Efficacy of Teclistamab

Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven100 enrolled17 locationsNCT06477783
Recruiting
Not Applicable

The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases

Hematologic Diseases
Meyer Children's Hospital IRCCS700 enrolled7 locationsNCT06857604
Recruiting
Phase 1

Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Diseases
He Huang29 enrolled1 locationNCT06809699
Recruiting

Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)

Hematologic DiseasesInherited BMF SyndromeInherited Platelet Disorder
Peter MacCallum Cancer Centre, Australia350 enrolled1 locationNCT05196789
Recruiting
Phase 4

Clinical Study of Combined Platelet Transfusion

Hematologic Diseases
The General Hospital of Western Theater Command86 enrolled1 locationNCT06613425
Recruiting
Phase 1

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NeoplasmsMultiple MyelomaCardiovascular Diseases+11 more
OriCell Therapeutics Co., Ltd.81 enrolled1 locationNCT06271252
Recruiting

Rapid Analysis of Infections by Spectrometry of Exhaled Breath

Hematologic DiseasesRespiratory Tract Infections
Universitaire Ziekenhuizen KU Leuven246 enrolled1 locationNCT03299608
Recruiting
Not Applicable

Naturopathic-pharmacological Consultation in Hematology

Hematologic Diseases
Bnai Zion Medical Center100 enrolled1 locationNCT05982262